Fortune Recommends™ Health is editorially independent. We may earn affiliate revenue from links in this content. Learn more . Fortune Recommends™ is editorially independent. We earn a commission for ...

Merck (MRK) and Daiichi Sankyo (DSNKY) announce early results from a Phase 2 trial of lung cancer drug I-DXd, an antibody ...

Keytruda shows promise as a first line option in cervical cancer cutting patients' mortality risk by a third in a Phase 3 ...

The FDA issued draft guidance on oncology clinical trials, taking the first steps toward formalizing a position that it's ...

On Sunday September 23, the flagship Forbes Under 30 Summit kicked off in Cincinnati, Ohio, bringing together the brightest ...

Vermont is beautiful in all four seasons, and exploring the mountains and valleys on foot is one of the most enchanting ...

Bob Duggan’s success shows you don’t need a Ph.D., or even a college education, to make money in the complex world of biotech ...

(Yicai) Sept. 13 -- China’s five-year business outlook looks mixed to US firms operating in the country, as some industries ...

UK government’s £500m taxpayer-backed deal for steelworks secures long-term future of Port Talbot but unable to secure guarantees to save 2,500 jobs ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

Bicara Therapeutics, a clinical-stage biopharmaceutical company, focuses on brining transformative bifunctional therapies for ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...